ArticleInternational journal of surgery case reports2020
Facilitating heart transplantability in an end-stage heart failure patient with brain abscess and infected left ventricle assist device-A unique case report.
Article in International journal of surgery case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE-VT trial.European journal of heart failure · 2025Article
- Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience.Interactive cardiovascular and thoracic surgery · 2022Article
- Safety, Mortality, and Hemodynamic Impact of Patients with MitraClip Undergoing Left Ventricular Assist Device Implantation.Journal of cardiovascular translational research · 2022Article
- Catheter ablation for atrial fibrillation in patients with end-stage heart failure and eligibility for heart transplantation.ESC heart failure · 2021Article
- Addition of levosimendan to overcome acute cardiogenic shock-Paving the way for later heart transplantation-A first case report.Clinical case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHeart transplantation is the desired therapy in end-stage heart failure (HF) and in patients with left-ventricular assist devices (LVAD) suffering from life-threatening complications on device. Comorbidities are frequent in end-stage HF and may refrain the patient from being listed for heart transplantation such as infections making surgery impossible. PRESENTATION OF CASE: We report the first case of a patient with proven LVAD system infection who additionally suffers from a brain abscess that made listing for heart transplantation impossible, leaving this patient no apparent treatment option.
conclusionOur extraordinary treatment strategy finally resolved both the brain abscess and LVAD system infection through extensive conservative long-term treatment facilitating this patient to be finally listed for regular heart transplantation and sustained relieve of systemic infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.